Mucosal melanoma of the head and neck: recurrence characteristics and survival outcomes
Related Experiment Video
Updated: Apr 5, 2026
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Faruk Kadri Bakkal1, Adil Başman2, Yusuf Kızıl1
1Department of Otorhinolaryngology, Gazi University School of Medicine, Ankara, Turkey.
Objective:
The aim of this study was to review oncologic outcomes and recurrence characteristics of head and neck mucosal melanomas (HNMMs) managed at a tertiary referral center.
Study Design:
Clinical records of 10 patients who were managed for HNMMs between 2001 and 2013 were retrospectively analyzed.
Results:
The median age was 66 years (range 28-76 years) and male/female (M/F) ratio was 1:5. The 3-year disease-free survival (DFS) rates and overall survival (OS) rates were 11.7% and 35%, respectively; and the 5-year DFS rates and OS rates 11.7% and 23.3%, respectively. The median DFS and OS periods were 12 months (range 2-36 months) and 17 months (range 7-96 months), respectively. The rates of development of local, regional, and systemic recurrences were 20%, 50%, and 80%, respectively. Lungs were involved in all patients who had distant metastasis.
Conclusions:
This study shows that HNMMs has a very aggressive course and that distant metastases are common. For this reason, systemic control of the disease is an important aim of treatment.
